Evidence map›Paper›PMID 42740904›Full record

ReviewCurrent therapeutic research, clinical and experimental2026

Dna aneuploidy and urothelial carcinoma: A meta-analysis.

Siying He, Miao Fu, Shuwei Fan, Pengfei Zhou, Junqi Wu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current therapeutic research, clinical and experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Siying HeDepartment of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365, East Renmin Rd, Zhejiang, Jinhua, PR China.
Miao FuDepartment of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365, East Renmin Rd, Zhejiang, Jinhua, PR China.
Shuwei FanDepartment of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365, East Renmin Rd, Zhejiang, Jinhua, PR China.
Pengfei ZhouDepartment of Urinary Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365, East Renmin Rd, Zhejiang, Jinhua, PR China.
Junqi WuDepartment of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365, East Renmin Rd, Zhejiang, Jinhua, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Urothelial carcinoma (UC) is regarded as the third most common cancer in adults, with a high incidence and mortality rate, and lacks specific tumor markers. With the advancement of technology, DNA ploidy analysis technology has become more convenient and efficient. Through meta-analysis of the correlation between DNA aneuploidy rate and UC prognosis, a more efficient UC prognosis indicator was discovered. Methods: Through searching PubMed, Web of Science, Embase and Cochrane Library database, we were able to identify the studies evaluating the prognostic value of DNA aneuploidy in UC. Results: In all, 15 citations were included in this meta-analysis. Pooled results showed that DNA aneuploidy was significantly corrected with poor OS (HR = 4.32, 95% CI = 2.39-7.81, Conclusion: Our meta-analysis showed the clinical value of DNA aneuploidy and its prognostic value in UC.

Indexed as

DNA aneuploidyMeta-analysisPrognosisUrothelial carcinoma

Identifiers

PMID42740904
PMCPMC13571958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.